- Home
- AGR vs SMMT Comparison
AGR vs SMMT Comparison
Compare AGR & SMMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGR
- SMMT
- Stock Information
- Founded
- AGR 1847
- SMMT 2003
- Country
- AGR United States
- SMMT United States
- Employees
- AGR N/A
- SMMT N/A
- Industry
- AGR Electric Utilities: Central
- SMMT Biotechnology: Pharmaceutical Preparations
- Sector
- AGR Utilities
- SMMT Health Care
- Exchange
- AGR Nasdaq
- SMMT Nasdaq
- Market Cap
- AGR 14.0B
- SMMT 14.5B
- IPO Year
- AGR N/A
- SMMT N/A
- Fundamental
- Price
- AGR $35.58
- SMMT $16.98
- Analyst Decision
- AGR Sell
- SMMT Strong Buy
- Analyst Count
- AGR 3
- SMMT 6
- Target Price
- AGR $34.50
- SMMT $33.33
- AVG Volume (30 Days)
- AGR 622.4K
- SMMT 1.9M
- Earning Date
- AGR 10-22-2024
- SMMT 10-30-2024
- Dividend Yield
- AGR 4.96%
- SMMT N/A
- EPS Growth
- AGR 111.64
- SMMT N/A
- EPS
- AGR 2.90
- SMMT N/A
- Revenue
- AGR $8,705,000,000.00
- SMMT N/A
- Revenue This Year
- AGR $2.67
- SMMT N/A
- Revenue Next Year
- AGR $3.35
- SMMT N/A
- P/E Ratio
- AGR $12.24
- SMMT N/A
- Revenue Growth
- AGR 6.35
- SMMT N/A
- 52 Week Low
- AGR $29.71
- SMMT $2.10
- 52 Week High
- AGR $37.70
- SMMT $33.89
- Technical
- Relative Strength Index (RSI)
- AGR 42.15
- SMMT 39.64
- Support Level
- AGR $35.52
- SMMT $17.80
- Resistance Level
- AGR $35.73
- SMMT $19.18
- Average True Range (ATR)
- AGR 0.11
- SMMT 1.12
- MACD
- AGR -0.02
- SMMT -0.00
- Stochastic Oscillator
- AGR 16.31
- SMMT 15.44
About AGR Avangrid Inc.
Avangrid operates two business units, Networks and Renewables. Networks operates eight regulated electric and natural gas utilities across New York, Maine, Connecticut, and Massachusetts, serving over 3 million customers. Renewables has historically focused on developing onshore wind projects but is looking to make developments in solar and offshore wind over the next five years. It operates nearly 8.6 gigawatts of renewable energy projects across the U.S. Spanish utility Iberdrola spun off Avangrid's predecessor, Iberdrola USA, in 2015. Iberdrola owns 81.6% of Avangrid and has proposed to acquire the remaining shares.
About SMMT Summit Therapeutics Inc.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.